1. TNF neutralization in MS: Results of a randomized, placebo controlled, multicenter study. Lenercept Multiple Sclerosis Study Group;Arnason;Neurology,1999
2. Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis;Badger;Arthritis Rheum,2000
3. A Comparison of etanercept and methotrexate in patients with early rheumatoid arthritis;Bathon;N Engl J Med,2001
4. Combination benefit of treatment with recombinant human interleukin-1 receptor antagonist (IL-1ra) and PEGylated recombinant human soluble tumor necrosis factor type 1 (PEG sTNF-R1) in animal models of rheumatoid arthritis [abstract];Bendele;Arthritis Rheum,2000
5. The role of tumor necrosis factor in health and disease;Beutler;J Rheumatol,1999